EXHIBIT 10.73
                                  -------------

                                       ivp
                                   technology

                                  June 16, 2003
Mr. Thomas S. Rohrer
SCI Healthcare Group, Inc.
8510 Egret Lakes Lane
West Palm Beach, FL 33412

                                LETTER OF INTENT

     The intent of this letter  ("letter")  is to summarize  recent  discussions
between the management of SCI Healthcare Group, Inc. ("SCI" or "Vendor") and IVP
Technology  Corporation  ("IVP")  together (the "Parties") with respect to IVP's
proposal to acquire  substantially  all of the assets  (excluding  cash and cash
equivalents)  and service  agreements for the Lindsay Division of SCI consulting
business - for ease of use ("Newco").  Therefore,  the principal purpose of this
letter is to document the terms, in general,  under which the transaction  would
take place subject to due diligence on the part of the Parties,  the approval of
the Parties' board of directors;  approval of Cornell Capital Partners LP within
twenty (20) days from the date of this letter and approval  from any  regulatory
agency in the United States that may have a regulatory-interest  in the proposed
transaction.

     It is  understood  by  both  parties  that  in  the  preparation  of  legal
agreements  that will give effect to this  transaction  certain  arrangements to
maximize  the tax  benefit  or other  benefits  to both  parties  may need to be
undertaken.  Each of IVP and NEWCO will  undertake to  accommodate  each other's
requirements  to the fullest  extent  possible  provided  however  that  neither
company will knowingly fail to comply with any regulation or statute in the US.


                         PRINCIPAL TERMS AND CONDITIONS

     The principal terms and conditions for the proposed purchase of 100% of the
assets

     An equivalent  number of shares equal to USD 200,000,  based on the average
closing bid price of IVP Technology Corporation shares thirty (30) days prior to
and two  days  following  the date of  closing  ("IVP  Shares").  At the time of
closing the shares will be  restricted  from trading by rule 144 for a period of
one year from date of issuance.  If IVP  registers any Shares within the one (1)
year period  immediately after Closing,  then it shall include the IVP Shares in
the registration thereby shortening the holding period.

     A cash payment of USD 200,000 US dollars at Closing:

<PAGE>

     o  Non-compete  agreements  signed  by all  employees  restricting  certain
        competitive activities for a period of one (1) year

     o  Retention agreements signed for and with all employees

     o  Assignment  of all material  contracts  with  suppliers and customers or
        other acceptable assurance of business continuity

     o  Retention of Mr.  Thomas  Rohrer as  commission  only  salesperson  on a
        non-exclusive basis

     o  Assignment  and  retention  of all  material  strategic  partnership  or
        reseller/integration  agreements with ISV's or other  suppliers/referral
        or other business component

     o  SCI to provide a copy of web based resume system for use by NEWCO in "AS
        IS" condition and a copy of the contact management data base

     Ms. Rhonda Lindsay to be appointed as GM of NEWCO and to be provided with a
3 year employment contract which will detail performance  criteria for which she
will be entitled to earn shares in IVP Technology.

II.  LOCK UP AND CONFIDENTIALITY

     It is  hereby  expressly  agreed  that  SCI  and  any of its  shareholders,
managers  or  advisors  will not engage in a process of seeking  any other buyer
until the  earlier  of July 31,  2003 or  cessation  of  negotiations.  SCI also
undertakes  to refrain from  discussing  the potential  acquisition  with any of
IVP's competitors except as agreed to by IVP for said period.

     If IVP and SCI have not completed the  acquisition  by August 30, 2003 then
this letter of intent shall terminate, with the exception of the confidentiality
provisions, non-solicitation provisions.

III. ASSUMED CLOSING DATE:

     August 30, 2003

IV.  CONDITIONS:

     The  purchase of SCI shall be subject to due  diligence by both parties and
their  respective  agents,  the  approval of the  Parties'  board of  directors,
Cornell  Capital  Partners  LLP,  within  thirty (30) days from the date of this
letter the US SEC  authorities  and  shareholders  if applicable  and subject to
counsel input from both IVP and SCI's legal and accounting advisors.

     SHARES.  The  common  shares  provided  as  partial  consideration  in this
transaction will be subject to rule 144 of the SEC.:

                                       2
<PAGE>

     EMPLOYMENT  OF  EXISTING  EMPLOYEES.  IVP will  offer  24 month  employment
agreements  to all  existing  employees  of  NEWCO  on  terms  equal to those in
existence at SCI. Employment will commence on the closing date.

     CONFIDENTIALITY. IVP and SCI will undertake to use every effort to maintain
the confidential nature of the proposed  transaction pending mutual agreement as
to any announcement and the terms of the existing Non-Disclosure Agreement dated
May 23, 2003 shall remain in full force and effect.  It is acknowledged that IVP
may have to disclose the pending  purchase as a result of SEC  requirements.  If
disclosure is required,  the parties will make a joint announcement  approved by
both  parties  and their  respective  counsel.  IVP  further  undertakes  not to
initiate any  conversations  or contacts with  competitors  prior to closing the
acquisition of NEWCO.

     LITIGATION.  To the best of knowledge  of IVP and SCI,  there is no action,
claim or demand or other  proceedings  pending or threatened before any court or
other administrative  agency, which would materially and adversely affect SCI or
IVP.

     CONDUCT. An undertaking by SCI that, pending the closing of the transaction
contemplated  herein, SCI shall have conducted Lindsay Division business only in
the ordinary course and there shall have occurred no material  adverse change to
SCI's Lindsay Division business or activities.

     DEFINITIVE  DOCUMENTATION.  It  is  understood  that  consummation  of  the
transaction  contemplated herein will be subject to-the  preparation;  execution
and delivery of a purchase and sale  agreement and such other  documentation  as
may be deemed  appropriate (the "Agreement") by legal and accounting  counsel to
IVP and SCI. Accordingly,  this letter with the exception of the confidentiality
and nonsolicitation provisions shall be a non-binding expressions of intent.

     APPLICABLE  LAW.  The  Agreement  to be  consummated  to give effect to the
transaction  herein  shall be  governed  by and  construed  and  interpreted  in
accordance  with the laws of the State of New Jersey and any actions with regard
thereto  shall be brought  only  within the Federal or state  courts  within the
State of New Jersey. As IVP is a public corporation traded on a recognized stock
market in the United  States and is a reporting  entity within the United States
of America in case of  difference  in the  regulatory  treatment  of  financial,
securities  and  accounting  matters  the laws and  regulations  of the US shall
apply.

     NON-SOLICITATION. IVP agrees on behalf of itself and all its affiliates not
to solicit or hire any  employees of SCI during the period of  negotiations  and
one (1) year thereafter with the exception of those employees  solicited  and/or
hired at the time of  Closing.  In  addition,  IVP  agrees  during the period of
negotiations  and one (1) year  thereafter  not to solicit  the  business of any
client of SCI it learned about or was provided  confidential  information  about
during negotiations or the due diligence procedure.

                                       3
<PAGE>



     ALL NOTICES under this Letter should be sent to:

IVP TECHNOLOGY CORPORATION at:             Brian J. MacDonald,
                                           President and CEO
                                           2275 Lakeshore Boulevard West
                                           Suite 401,
                                           Toronto, Ontario M8V 3Y3

SCI HEALTHCARE GROUP INC.                  Mr. Tom Rohrer
                                           Executive Vice President
                                           8510 Egrets Lake Lane
                                           West Palm Beach, Florida 33412

                                           With a copy to:
                                           Marc D. Freedman
                                           Freedman & Gersten, LLP
                                           777 Terrace Avenue-Fifth Floor
                                           Hasbrouck Heights, NJ 07604

     Dated this 26th day of June 2003.

     EXPENSES:  Each party shall bear its own  expenses and  attorneys'  fees in
connection  with the  preparation  of this  letter  and the  negotiation  of the
contemplated transaction.

EXECUTED:

IVP Technology Corporation                 SCI Healthcare Group Inc.


/S/ PETER HAMILTON                         /S/ THOMAS S. ROHRER
------------------------------             -------------------------------
/S/ EXECUTIVE VICE PRESIDENT               /S/ EXECUTIVE VICE PRESIDENT
/S/ PETER HAMILTON                         /S/ THOMAS ROHRER


                                       4